Literature DB >> 10710542

Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors.

H T Lee1, C W Emala.   

Abstract

Renal ischemia and reperfusion during aortic and renal transplant surgery result in ischemic-reperfusion injury. Ischemic preconditioning and adenosine infusion before ischemia protect against ischemic-reperfusion injury in cardiac and skeletal muscle, but these protective phenomena have not been demonstrated in the kidney. Rats were randomized to sham operation, 45-min renal ischemia, ischemic preconditioning with four cycles of 8-min renal ischemia and 5-min reperfusion followed by 45-min renal ischemia, systemic adenosine pretreatment before 45-min renal ischemia, or pretreatments with selective adenosine receptor subtype agonists or antagonists before 45-min renal ischemia. Forty-five minutes of renal ischemia followed by 24 h of reperfusion resulted in marked rises in blood urea nitrogen and creatinine. Ischemic preconditioning and adenosine pretreatment protected renal function and improved renal morphology. A(1) adenosine receptor activation mimics and A(1) adenosine antagonism blocks adenosine-induced protection. In addition, A(3) adenosine receptor activation before renal ischemia worsens renal ischemic-reperfusion injury, and A(3) adenosine receptor antagonism protects renal function. We demonstrate for the first time that rat kidneys can be preconditioned to attenuate ischemic-reperfusion injury and adenosine infusion before ischemic insult protects renal function via A(1) adenosine receptor activation. Our data suggest that an A(1) adenosine agonist and A(3) adenosine antagonist may have clinically beneficial implications where renal ischemia is unavoidable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10710542     DOI: 10.1152/ajprenal.2000.278.3.F380

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  61 in total

Review 1.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 2.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

3.  Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

Authors:  Z G Gao; J E Van Muijlwijk-Koezen; A Chen; C E Müller; A P Ijzerman; K A Jacobson
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 4.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

5.  Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Authors:  Ashish K Rehni; Kunjan R Dave
Journal:  Cond Med       Date:  2018-04-20

Review 6.  Adenosine receptors and the kidney.

Authors:  Volker Vallon; Hartmut Osswald
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Stimulation of the adenosine A3 receptor reverses vascular hyporeactivity after hemorrhagic shock in rats.

Authors:  Rong Zhou; Feng Chen; Qiang Li; De-yao Hu; Liang-ming Liu
Journal:  Acta Pharmacol Sin       Date:  2010-03-29       Impact factor: 6.150

8.  Role of adhesion molecules and dendritic cells in rat hepatic/renal ischemia-reperfusion injury and anti-adhesive intervention with anti-P-selectin lectin-EGF domain monoclonal antibody.

Authors:  Tong Zhou; Gui-Zhi Sun; Ming-Jun Zhang; Jin-Lian Chen; Dong-Qing Zhang; Qing-Shen Hu; Yu-Ying Chen; Nan Chen
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

9.  Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Authors:  Katalin Módis; Domokos Gero; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

10.  Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi; Dongmei Cheng; Rashmi Bansal; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.